カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の結核診断市場（2023-2030）：検査種類別（放射線法、臨床検査法、核酸検査、ファージアッセイ）、エンドユーザー別、地域別

【英語タイトル】Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV184）・商品コード：GRV23NOV184
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：臨床診断
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,324,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

結核診断市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の結核診断市場規模は、2023年から2030年にかけて年平均成長率5.2%を記録し、2030年までに33億4000万米ドルに達する見込みです。インターフェロン-ガンマ放出アッセイ（IGRA）、血清学的手法、核酸検査などの高度な診断手法の登場により、診断薬の使用率は高くなっています。さらに、抗原アッセイなどのPOC（Point of Care）技術も結核の診断率を高めています。

POC診断を含むこれらの先進的な方法は、手頃な価格で正確かつ簡便であり、迅速な結果が得られます。さらに、結核の負担増が市場成長の主な要因となっています。世界保健機関（WHO）によると、2014年の結核患者の世界推計は約960万人でした。この高い有病率により、政府、医療機関、研究機関、市場関係者は、この感染症の発生を抑制するための努力を開始しました。

高負担地域における検診率の上昇、手頃な価格の診断薬、高度な方法論、迅速な臨床判断、死亡率の低下が開発の焦点となっています。予防的・治療的診断率の向上は、こうした取り組みの最終的な成果です。このため、診断検査に対する需要が急増し、結核診断市場が拡大しています。

結核診断市場レポートハイライト

- 検査タイプ別では、結核診断市場はX線検査法、診断ラボ法、核酸検査法、ファージアッセイ、潜伏感染検出法、サイトカイン検出アッセイ、薬剤耐性検出法に区分されます。

- 検査室診断検査は、コスト効率が高く、実施が容易であるため、2015年の市場シェアは38.0%で、検査タイプセグメントを支配しています。診断ラボ検査には塗抹顕微鏡検査と培養ベースの検査が含まれます。高負担地域では、先進技術を取り入れる財政的・技術的能力がないため、これらの方法論に依存しており、診断ラボ検査セグメントの成長に寄与しています。

- しかし、精度の低下と処理時間の長さが、この診断法の限界要因となっています。そのため、医療機関は発展途上地域で高度な技術の導入に努めています。

- その結果、核酸検査分野と、皮膚検査やIGRAを含む潜伏感染検出分野が収益性の高い成長率を示すと思われます。これらの方法は、前述の制限を克服することにより、診断法の手頃な価格、処理時間、精度を向上させます。

- 結核における薬剤耐性は、医療専門家にとって主要な懸念事項の1つです。なぜなら、誤った薬剤レジメンや誤った剤形による不適切な治療が、治療中の結核患者における薬剤耐性の発現につながるからです。したがって、薬剤耐性検出分野もまた、有利な成長を目撃すると予測されています。

- 膨大な人口と結核の高負担を背景に、2015年の結核診断市場はアジア太平洋地域が世界を席巻しました。WHOによると、インド、中国、アフガニスタン、インドネシアなどの国々は、この伝染病の制御のための優先地域です。

- 結核検査市場のプレーヤーは、Thermo Fisher Scientific, Inc.、Hologic Corporation、Abbott Laboratories、Alere, Inc.、Becton, Dickinson and Company、F. Hoffmann-La Roche AG、bioMérieux SA、Sanofi、Cepheid、Hain Lifescience GmbH、QIAGENなどです。

- 新製品の発売、提携、M&A、地域拡大は、これらの業界プレーヤーが行う主要な戦略的イニシアチブです。

- 例えば、2016年7月、bioMérieuxは、結核の同定のための新しいCEマークのデータベースと試薬キットVITEK MSを発売しました。この新製品の発売は、同社の市場シェア拡大に貢献すると期待されています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界の結核診断市場：検査タイプ別予測・動向分析
第5章. 世界の結核診断市場：最終用途別予測・動向分析
第6章. 世界の結核診断市場：地域別予測・動向分析
第7章. 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Test Type
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test type outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Tuberculosis Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Tuberculosis Diagnostics Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Tuberculosis Diagnostics: Test Type Estimates & Trend Analysis
4.1. Tuberculosis Diagnostics Market: Key Takeaways
4.2. Tuberculosis Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Radiographic Method
4.3.1. Radiographic method market estimates and forecasts, 2018 to 2030, (USD Million)
4.4. Diagnostic Laboratory Methods
4.4.1. Diagnostic laboratory methods market estimates and forecasts, 2018 to 2030, (USD Million)
4.5. Nucleic Acid Testing
4.5.1. Nucleic acid testing market estimates and forecasts, 2018 to 2030, (USD Million)
4.6. Phage Assay
4.6.1. Phage assay market estimates and forecasts, 2018 to 2030, (USD Million)
4.7. Detection of Latent Infection (Skin Test & IGRA)
4.7.1. Detection of latent infection market estimates and forecasts, 2018 to 2030, (USD Million)
4.8. Cytokine Detection Assay
4.8.1. Cytokine detection assay market estimates and forecasts, 2018 to 2030, (USD Million)
4.9. Detection of Drug Resistance (DST)
4.9.1. Detection of drug resistance (DST) market estimates and forecasts, 2018 to 2030, (USD Million)
4.10. Other Methods
4.10.1. Other methods market estimates and forecasts, 2018 to 2030, (USD Million)
Chapter 5. Tuberculosis Diagnostics: End-use Estimates & Trend Analysis
5.1. Tuberculosis Diagnostics Market: Key Takeaways
5.2. Tuberculosis Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Diagnostic Laboratories
5.3.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030, (USD Million)
5.4. Hospitals & Clinics
5.4.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030, (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2018 to 2030, (USD Million)
Chapter 6. Tuberculosis Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Tuberculosis Diagnostics Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Abbott Laboratories
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Becton, Dickinson and Company
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. F. Hoffmann-La Roche AG
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Thermo Fisher Scientific Inc.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. BioMérieux SA
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Hain Lifescience GmbH
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. QIAGEN GmbH
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Cepheid
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Hologic, Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. BD
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 North America tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 3 North America tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 4 North America tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 6 U.S. tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 7 Canada tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 8 Canada tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 9 Europe tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 10 Europe tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 11 Europe tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
Table 12 Germany tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 13 Germany tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 14 UK tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 15 UK tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 16 France tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 17 France tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 18 Italy tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 19 Italy tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 20 Spain tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 21 Spain tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 22 Sweden tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 23 Sweden tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 24 Norway tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 25 Norway tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 26 Denmark tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 27 Denmark tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 29 Asia Pacific tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
Table 31 China tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 32 China tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 33 Japan tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 34 Japan tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 35 India tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 36 India tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 37 Australia tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 38 Australia tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 39 Thailand tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 40 Thailand tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 41 South Korea tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 42 South Korea tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 43 Latin America tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 44 Latin America tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 45 Latin America tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 47 Brazil tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 48 Mexico tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 49 Mexico tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 50 Argentina tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 51 Argentina tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 56 South Africa tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 59 UAE tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 60 UAE tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 61 Kuwait tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 62 Kuwait tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million) 

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Tuberculosis diagnostics: Market outlook
Fig. 9 Tuberculosis diagnostics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Tuberculosis diagnostics market driver impact
Fig. 15 Tuberculosis diagnostics market restraint impact
Fig. 16 Tuberculosis diagnostics market strategic initiatives analysis
Fig. 17 Tuberculosis diagnostics market: Test type movement analysis
Fig. 18 Tuberculosis diagnostics market: Test type outlook and key takeaways
Fig. 19 Radiographic method market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Diagnostic laboratory methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Nucleic acid testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Phage assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Detection of latent infection (skin test & IGRA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Cytokine detection assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Detection of drug resistance (DST) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Other methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Tuberculosis diagnostics market: End-use movement analysis
Fig. 28 Tuberculosis diagnostics market: End-use outlook and key takeaways
Fig. 29 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Global tuberculosis diagnostics market: Regional movement analysis
Fig. 33 Global tuberculosis diagnostics market: Regional outlook and key takeaways
Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

★調査レポート[世界の結核診断市場（2023-2030）：検査種類別（放射線法、臨床検査法、核酸検査、ファージアッセイ）、エンドユーザー別、地域別] (コード：GRV23NOV184)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の結核診断市場（2023-2030）：検査種類別（放射線法、臨床検査法、核酸検査、ファージアッセイ）、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の医薬品無菌性試験市場（2023-2030）：製品種類別（装置、サービス）、種類別（アウトソーシング、インハウス）、検査種類別、サンプル別、エンドユーザー別、地域別
  • 世界の前立腺がん診断薬市場（2023-2030）：検査種類別（予備検査、確認検査）、種類別（腺がん、間質細胞がん）、エンドユーザー別（病院、外来施設）、地域別
  • 世界のHIV診断市場2023-2030：製品別（消耗品、機器）、検査種類別（抗体検査、ウイルス負荷検査）、モード別（自己検査、研究所ベース）、エンドユーザー別、地域別
  • 世界の内分泌検査市場2023-2030：検査種類別（FSH、インスリン）、技術別（タンデム質量分析、イムノアッセイ）、エンドユーザー別、地域別
  • 世界の新生児スクリーニング市場（2023-2030）：技術別（タンデム質量分析、パルスオキシメトリ）、検査種類別、製品別（装置、試薬）、地域別
  • 世界の心不全用POC・LOC機器市場2023-2030：検査種類別、技術別（マイクロ流体、アレイベースシステム）、エンドユーザー別（診療所、病院、生活支援医療施設）、地域別
  • 世界の体外大腸がんスクリーニング検査市場（2023-2030）：検査種類別（便潜血検査、バイオマーカー検査、CRC DNAスクリーニング検査）、地域別
  • 世界の子宮頸がん診断市場2023-2030：検査種類別（パップテスト/細胞診検査、HPV検査、コルポスコピー、子宮頸部生検）、年齢層別、エンドユーザー別、地域別
  • 世界のHIV/AIDS診断市場（2022-2031）：製品別（キット＆試薬、機器）、検査種類別（核酸検査、迅速検査、ELISA、その他）
  • 世界の呼吸器疾患検査市場（2023-2030）：製品別（画像検査、呼吸計、血液ガス検査）、エンドユーザー別、用途別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆